MX9702926A - L-eritrosilnucleosidos. - Google Patents
L-eritrosilnucleosidos.Info
- Publication number
- MX9702926A MX9702926A MX9702926A MX9702926A MX9702926A MX 9702926 A MX9702926 A MX 9702926A MX 9702926 A MX9702926 A MX 9702926A MX 9702926 A MX9702926 A MX 9702926A MX 9702926 A MX9702926 A MX 9702926A
- Authority
- MX
- Mexico
- Prior art keywords
- erythrosyl
- nucleosides
- mammals
- beta
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Esta invencion se relaciona con alfa y beta-L-eritrosilnucleosidos, con procesos para su preparacion, con composiciones farmacéuticas que los contienen y métodos de utilizarlos para tratar varias enfermedades en mamíferos.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/328,301 US5672594A (en) | 1994-10-24 | 1994-10-24 | L-erythrosyl nucleosides |
US328301 | 1995-10-24 | ||
US328,301 | 1995-10-24 | ||
PCT/US1995/013697 WO1996013498A2 (en) | 1994-10-24 | 1995-10-24 | L-erythrosyl nucleosides |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA97002926A MXPA97002926A (es) | 1998-04-01 |
MX9702926A true MX9702926A (es) | 1998-04-30 |
Family
ID=23280408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9702926A MX9702926A (es) | 1994-10-24 | 1995-10-24 | L-eritrosilnucleosidos. |
Country Status (5)
Country | Link |
---|---|
US (1) | US5672594A (es) |
EP (1) | EP0788495A2 (es) |
JP (1) | JPH10507771A (es) |
MX (1) | MX9702926A (es) |
WO (1) | WO1996013498A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ126799A3 (cs) * | 1996-10-16 | 1999-07-14 | Icn Pharmaceuticals | Purinové L-nukleosidy a jejich analogy a farmaceutické prostředky, které je obsahují |
EP1302474A1 (en) * | 1996-10-16 | 2003-04-16 | Ribapharm, Inc. | Monocyclic L-nucleosides, analogs and uses thereof |
PL187107B1 (pl) * | 1996-10-16 | 2004-05-31 | Icn Pharmaceuticals | L-nukleozydy monocykliczne, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie |
US6090602A (en) | 1998-02-18 | 2000-07-18 | Promelas Research Corporation | Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent |
CA2322494A1 (en) * | 1998-03-11 | 1999-09-16 | Annette M. Gero | Novel nucleoside analogs and uses in treating disease |
US6525191B1 (en) * | 1999-05-11 | 2003-02-25 | Kanda S. Ramasamy | Conformationally constrained L-nucleosides |
WO2002057287A2 (en) * | 2001-01-22 | 2002-07-25 | Merck & Co., Inc. | Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
US8481712B2 (en) | 2001-01-22 | 2013-07-09 | Merck Sharp & Dohme Corp. | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
US9156872B2 (en) | 2011-04-13 | 2015-10-13 | Merck Sharp & Dohme Corp. | 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
AU2012242978A1 (en) | 2011-04-13 | 2013-10-24 | Merck Sharp & Dohme Corp. | 2'-Cyano Substituted Nucleoside Derivatives and methods of use thereof for the treatment of viral diseases |
EP2696681B1 (en) | 2011-04-13 | 2018-10-03 | Merck Sharp & Dohme Corp. | 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
WO2013009737A1 (en) | 2011-07-13 | 2013-01-17 | Merck Sharp & Dohme Corp. | 5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases |
US9416154B2 (en) | 2011-07-13 | 2016-08-16 | Merck Sharp & Dohme Corp. | 5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2648239C3 (de) * | 1975-10-24 | 1981-11-12 | Rikagaku Kenkyusho, Wako, Saitama | Di-(trialkylstannyl)-pyrimidinderivate, Verfahren zu ihrer Herstellung und Verfahren zu ihrer Weiterverarbeitung zu nucleosidartigen Pyrimidinderivaten |
DD140254A1 (de) * | 1978-12-04 | 1980-02-20 | Dieter Baerwolff | Verfahren zur herstellung von 4-substituierten pyrimidin-nucleosiden |
DD228810A1 (de) * | 1984-10-18 | 1985-10-23 | Adw Ddr | Verfahren zur herstellung von cycloalkylether-derivaten des 6- fluorthymins |
JPS61145167A (ja) * | 1984-12-18 | 1986-07-02 | Sagami Chem Res Center | 1,3−二置換−5−フルオロ−6−クロロウラシル誘導体及び抗腫瘍剤 |
KR910009957B1 (ko) * | 1989-12-29 | 1991-12-07 | 한국과학기술원 | 2-푸릴피리미딘 유도체의 제조방법 |
-
1994
- 1994-10-24 US US08/328,301 patent/US5672594A/en not_active Expired - Fee Related
-
1995
- 1995-10-24 MX MX9702926A patent/MX9702926A/es not_active IP Right Cessation
- 1995-10-24 WO PCT/US1995/013697 patent/WO1996013498A2/en not_active Application Discontinuation
- 1995-10-24 JP JP8514685A patent/JPH10507771A/ja not_active Ceased
- 1995-10-24 EP EP95940545A patent/EP0788495A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US5672594A (en) | 1997-09-30 |
EP0788495A2 (en) | 1997-08-13 |
WO1996013498A2 (en) | 1996-05-09 |
JPH10507771A (ja) | 1998-07-28 |
WO1996013498A3 (en) | 1996-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9702932A (es) | L-ribofuranosilnucleosidos. | |
IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
ATE179330T1 (de) | Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute | |
UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
MX9705296A (es) | Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia. | |
IL110091A0 (en) | Imidazo [4,5-c] pyridin-4-amines and pharmaceutical compositions containing them | |
BG101118A (en) | Therapeutical compounds | |
FR2707882B1 (fr) | Nouveaux kits thérapeutiques anti-médiateurs protéiques, procédé de préparation et compositions pharmaceutiques les renfermant. | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
MX9702926A (es) | L-eritrosilnucleosidos. | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
DE69911401D1 (en) | Immunoregulator | |
PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
SG52537A1 (en) | Methods and compositions for the treatment of cell proliferation disorders | |
FR2651435B1 (es) | ||
MX9702927A (es) | L-piranosilnucleosidos. | |
MX9800049A (es) | Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso. | |
PL318130A1 (en) | Terpenod derivatives (of sarcodictyine)as antineoplastic agents | |
GR3020575T3 (en) | New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions | |
ES2016464A6 (es) | Procedimiento para preparar derivados de 2', 5' -oligoadenilato. | |
MD960168A (ro) | Metodă şi compuşi pentru tratamentul infecţiilor virale | |
ES8607217A1 (es) | Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas | |
IL88726A0 (en) | Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
UA37217C2 (uk) | Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, фармацевтична композиція та проміжні сполуки |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |